VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Experian plc vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Experian plc
EXPN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Experian plc's moat claims, evidence, and risks.
View EXPN analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: Experian plc leads (76 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: Experian plc has 4 segments (67.2% in North America); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: Experian plc has 7 moat types across 4 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
Experian plc
North America
Consumer and business credit reporting, identity/fraud data and decision analytics, plus consumer credit/insurance marketplaces
North America
Financial institutions, insurers, auto lenders, healthcare providers, advertisers, consumers
Data/analytics provider and consumer marketplace operator
67.2%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
Experian plc strengths
Merck & Co., Inc. strengths
Segment mix
Experian plc segments
Full profile >North America
Oligopoly
Latin America
Quasi-Monopoly
UK and Ireland
Oligopoly
EMEA and Asia Pacific
Competitive
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.